Co-Authors
This is a "connection" page, showing publications co-authored by Fu-Sheng Wang and Tian-Jun Jiang.
Connection Strength
0.841
-
Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial. Signal Transduct Target Ther. 2020 08 27; 5(1):172.
Score: 0.225
-
Single-cell landscape of immunological responses in patients with COVID-19. Nat Immunol. 2020 09; 21(9):1107-1118.
Score: 0.224
-
Predictors of Coronavirus Disease 2019 Severity: A Retrospective Study of 64 Cases. Jpn J Infect Dis. 2021 Jan 22; 74(1):54-60.
Score: 0.224
-
Increased circulating level of interleukin-6 and CD8+ T cell exhaustion are associated with progression of COVID-19. Infect Dis Poverty. 2020 Nov 25; 9(1):161.
Score: 0.057
-
Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun. 2020 07 08; 11(1):3410.
Score: 0.056
-
Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis. Cell Metab. 2020 08 04; 32(2):188-202.e5.
Score: 0.056